Clinical trial
Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ…
NCT00472459 · Galderma R&D, Industry · Completed
Key facts
| NCT number | NCT00472459 |
|---|---|
| Title | Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer |
| Official title | A Multicenter, Randomized Study of Photodynamic Therapy (PDT) With Metvix® 160 mg/g Cream in Immuno-compromised Patients With Non-melanoma Skin Cancer |
| Lead sponsor | Galderma R&D, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Actinic Keratosis, Warts, Basal Cell Carcinoma, Bowens Disease, Squamous Cell Carcinoma |
| Intervention type | Procedure |
| Interventions | Photodynamic therapy with Metvix 160 mg/g cream |
| Enrollment | 82 |
| Start date | Jul 25, 2003 |
| Primary completion | Sep 23, 2004 |
| Completion | Jul 14, 2006 |
| First posted | May 11, 2007 |
| Last update posted | Apr 18, 2025 |
| Countries | Denmark, Germany, Norway, Sweden, United Kingdom |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: